Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can lung ultrasound reveal COVID-19's signature in the lungs?

NCT ID NCT04341766

Diagnosis Sponsor: Centre Hospitalier Intercommunal Creteil Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 15, 2026 · Last updated Sep 16, 2026 · Updated 1 time

Summary

Researchers are studying whether lung ultrasound can reliably show the patterns of COVID-19 pneumonia in hospitalized patients. The trial enrolls adults admitted with confirmed COVID-19 and respiratory symptoms who need a chest CT scan. By comparing ultrasound images with CT scans over time, the team aims to describe what COVID-19 looks like on ultrasound and how those signs change during hospitalization.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If lung ultrasound proves reliable for spotting COVID-19 pneumonia patterns, doctors could use it as a fast, bedside tool to assess and monitor patients without moving them to a CT scanner.
What could go wrong
This is a small observational study with no comparison group, so the ultrasound patterns it describes may not be specific to COVID-19 or may not apply to other patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

106 people

The number who actually took part.

Started

Mar 2020

Finished

Jun 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patient admitted to hospital with proven COVID-19 infection with respiratory signs and who need an hospitalization

Ages

18 to 105 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients admitted to hospital with proven COVID-19 infection with respiratory signs warranting a chest CT scan Exclusion Criteria: * Patient not agreeing to have his or her data collected for the study * Unconscious patient

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID -19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 viral pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID -19 Pneumonia, viral

Contacts and locations

Locations

  • APHM - Hopital Nord

    Marseille, 13015, France

  • CH Saint-Quentin

    Saint-Quentin, 02321, France

  • CH de la Côte Basque

    Bayonne, 64109, France

  • CHG de Chambery

    Chambéry, 73000, France

  • CHR Orléans

    Orléans, 45100, France

  • CHU Ambroise Paré

    Boulogne-Billancourt, 92104, France

  • CHU Amiens

    Amiens, 80054, France

  • CHU Caen

    Caen, 14033, France

  • CHU Cochin

    Paris, 75679, France

  • CHU Larrey - Toulouse

    Toulouse, 31059, France

  • CHU Nîmes

    Nîmes, 30029, France

  • CHU Poitiers

    Poitiers, 86021, France

  • CHU Rouen

    Rouen, 76038, France

  • CHU de Limoges

    Limoges, 87000, France

  • CHU de Nancy

    Nancy, 54035, France

  • CHU de Tours

    Tours, 37000, France

  • Centre Hospitalier Intercommunal de Créteil

    Créteil, 94000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.